These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38274221)

  • 21. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.
    Koh YX; Tan HL; Lye WK; Kam JH; Chiow AKH; Tan SS; Choo SP; Chung AYF; Goh BKP
    World J Hepatol; 2018 Jun; 10(6):433-447. PubMed ID: 29988922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lobar Radioembolization for Intermediate and Advanced Hepatocellular Carcinoma: Retrospective and Prospective Data.
    Lakhoo J; Perez TH; Borgmann AJ; Brown DB
    Semin Intervent Radiol; 2021 Oct; 38(4):412-418. PubMed ID: 34629707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.
    Titano J; Noor A; Kim E
    Semin Intervent Radiol; 2017 Jun; 34(2):109-115. PubMed ID: 28579678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review.
    He ZX; Xiang P; Gong JP; Cheng NS; Zhang W
    Ther Clin Risk Manag; 2016; 12():295-303. PubMed ID: 26966370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updated treatment approach to hepatocellular carcinoma.
    Llovet JM
    J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
    Mukund A; Vats P; Jindal A; Patidar Y; Sarin SK
    J Clin Exp Hepatol; 2020; 10(6):563-573. PubMed ID: 33311893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updates on the Diagnosis and Management of Hepatocellular Carcinoma.
    Raees A; Kamran M; Özkan H; Jafri W
    Euroasian J Hepatogastroenterol; 2021; 11(1):32-40. PubMed ID: 34316462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm.
    Burak KW; Kneteman NM
    Can J Gastroenterol; 2010 Nov; 24(11):643-50. PubMed ID: 21157578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
    World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
    Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review.
    Miller FH; Lopes Vendrami C; Gabr A; Horowitz JM; Kelahan LC; Riaz A; Salem R; Lewandowski RJ
    Radiographics; 2021 Oct; 41(6):1802-1818. PubMed ID: 34559587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation Segmentectomy.
    Prachanronarong K; Kim E
    Semin Intervent Radiol; 2021 Oct; 38(4):425-431. PubMed ID: 34629709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curative-Intent Therapies in Localized Hepatocellular Carcinoma.
    O'Leary C; Mahler M; Soulen MC
    Curr Treat Options Oncol; 2020 Mar; 21(4):31. PubMed ID: 32193784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
    Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
    Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
    Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New horizons in ablation therapy for hepatocellular carcinoma.
    Freedman J; Nilsson H; Jonas E
    Hepat Oncol; 2015 Oct; 2(4):349-358. PubMed ID: 30191017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiation Segmentectomy/Lobectomy Using Yttrium 90-labeled Glass Microspheres.
    Kumar P; Mhaskar R; Kim R; Anaya D; Frakes J; Hoffe S; Choi J; Kis B
    J Clin Exp Hepatol; 2022; 12(5):1259-1263. PubMed ID: 36157145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.